Infectious Disease Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/infectious-disease/ The leading site for news and procurement in the pharmaceutical industry Fri, 05 Apr 2024 13:50:39 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Infectious Disease Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/infectious-disease/ 32 32 Q&A: BARDA wants to back tech that can combat multiple infections, says director https://www.pharmaceutical-technology.com/interviews/qa-barda-chief-says-agency-looks-to-back-tech-that-can-combat-multiple-infections/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1674044449-scaled.jpg Fri, 05 Apr 2024 07:42:56 +0000 https://www.pharmaceutical-technology.com/interviews/qa-barda-chief-says-agency-looks-to-back-tech-that-can-combat-multiple-infections/ Johnson & Johnson’s paediatric HIV-1 treatment secures FDA approval https://www.pharmaceutical-technology.com/news/johnson-johnson-hiv-treatment-fda/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/Johnson.jpg Wed, 20 Mar 2024 10:35:11 +0000 https://www.pharmaceutical-technology.com/news/johnson-johnson-hiv-treatment-fda/ Merck to start trials investigating single dosing regimen of HPV vaccine https://www.pharmaceutical-technology.com/news/merck-to-start-trials-investigating-single-dosing-regiments-of-hpv-vaccine/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/shutterstock_690219232-1.jpg Wed, 13 Mar 2024 11:13:10 +0000 https://www.pharmaceutical-technology.com/?p=287798 Anticipation rises for RSV rollout as positive data emerges https://www.pharmaceutical-technology.com/features/anticipation-rises-for-rsv-rollout-as-positive-data-emerges/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/RSV-image-1.jpg Fri, 23 Feb 2024 15:09:24 +0000 https://www.pharmaceutical-technology.com/features/anticipation-rises-for-rsv-rollout-as-positive-data-emerges/ Bavarian Nordic’s chikungunya vaccine secures EMA fast-track https://www.pharmaceutical-technology.com/news/bavarian-nordics-chikungunya-vaccine-secures-ema-fast-track/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_1884373693.jpg Fri, 23 Feb 2024 12:31:53 +0000 https://www.pharmaceutical-technology.com/news/bavarian-nordics-chikungunya-vaccine-secures-ema-fast-track/ AstraZeneca completes Icosavax acquisition for $1.1bn https://www.pharmaceutical-technology.com/news/astrazeneca-icosavax-acquisition/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/astrazeneca-1.jpg Tue, 20 Feb 2024 08:28:11 +0000 https://www.pharmaceutical-technology.com/news/astrazeneca-icosavax-acquisition/ Thermo Fisher Scientific’s Biologics Manufacturing Facility Expansion, USA https://www.pharmaceutical-technology.com/projects/thermo-fisher-scientifics-biologics-manufacturing-facility-expansion-usa/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/Featured-Image-Thermo-Fisher-Biologics-Manufacturing-Facility-Expansion.jpg Tue, 13 Feb 2024 13:48:06 +0000 https://www.pharmaceutical-technology.com/?post_type=projects&p=281234 FDA grants fast track status to GSK’s bepirovirsen for hepatitis B https://www.pharmaceutical-technology.com/news/fda-fast-track-gsk-bepirovirsen/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/gsk-1.jpg Tue, 13 Feb 2024 08:36:04 +0000 https://www.pharmaceutical-technology.com/news/fda-fast-track-gsk-bepirovirsen/ Emergent wins $235.8m US defence contract for Anthrax vaccine https://www.pharmaceutical-technology.com/news/emergent-wins-235-8m-us-defence-contract-for-anthrax-vaccine/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_606192860.jpg Fri, 12 Jan 2024 12:41:56 +0000 https://www.pharmaceutical-technology.com/news/emergent-wins-235-8m-us-defence-contract-for-anthrax-vaccine/ Curevo looks to challenge GSK’s Shingrix with positive Phase II data https://www.pharmaceutical-technology.com/news/curevo-looks-to-challenge-gsks-shingrix-with-positive-phase-ii-data/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_1713212986.jpg Mon, 08 Jan 2024 11:12:03 +0000 https://www.pharmaceutical-technology.com/?p=271009